Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.

Serum creatinine > 3 mg/dl.

Liver dysfunction ( ³ 2 fold level of ALT and AST enzymes).

Participation in another trial in which active intervention is being received.

Any intestinal problem that would prevent the patient from eating one of the test diets (for example, gastric stapling that might prevent consumption of vegetables).

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00160108

Locations

Israel

Medical Center, The Nuclear Research Center

Dimona, Israel, 70700

Sponsors and Collaborators

The S. Daniel Abraham International Center for Health and Nutrition

Harvard School of Public Health

University of Western Ontario, Canada

Soroka University Medical Center

Brigham and Women's Hospital

Harvard Medical School

The Nuclear Research Center, Dimona

Ben-Gurion University of the Negev

Investigators

Principal Investigator:

Iris Shai, RD, PhD

Ben-Gurion University of the Negev

Study Chair:

Meir J Stampfer, MD, DrPH

Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA